
STRATA Skin Sciences SSKN
Quarterly report 2025-Q3
added 11-14-2025
STRATA Skin Sciences General and Administrative Expenses 2011-2026 | SSKN
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses STRATA Skin Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.1 M | 9.71 M | 7.9 M | 10.3 M | 8.79 M | 7.4 M | 7.64 M | 10 M | 11 M | 15.5 M | 14.2 M | 10.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.5 M | 7.4 M | 10.3 M |
Quarterly General and Administrative Expenses STRATA Skin Sciences
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.67 M | - | 3.62 M | 2.21 M | 2.71 M | - | 2.28 M | 2.49 M | 2.92 M | - | 2.62 M | 2.33 M | 2.65 M | - | 2.18 M | 2.12 M | 2.79 M | - | 1.93 M | 1.89 M | 2.1 M | - | 2.22 M | 2.7 M | 2.48 M | - | 2.29 M | 2.41 M | 1.88 M | - | 1.79 M | 1.84 M | 1.71 M | - | 1.88 M | 1.9 M | 2.1 M | - | 3.13 M | 1.95 M | 1.74 M | - | 1.88 M | 1.75 M | 3.2 M | - | 3.48 M | 4.67 M | 4.29 M | - | 3.47 M | 3.53 M | 3.22 M | - | 3.69 M | 2.21 M | 2.39 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.67 M | 1.71 M | 2.54 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.17 | -1.55 % | $ 119 M | ||
|
Electromed
ELMD
|
39.3 M | $ 25.61 | -1.52 % | $ 217 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | ||
|
Globus Medical
GMED
|
1.18 B | $ 92.82 | -0.94 % | $ 12.6 B | ||
|
AdaptHealth Corp.
AHCO
|
382 M | $ 13.19 | 0.84 % | $ 1.78 B | ||
|
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | ||
|
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.09 | -1.5 % | $ 1.27 M | ||
|
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | ||
|
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
45.2 M | $ 5.25 | 0.77 % | $ 62.8 M | ||
|
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | ||
|
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
554 M | $ 12.17 | -1.22 % | $ 482 M | ||
|
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.64 | 5.38 % | $ 39.8 M | ||
|
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | ||
|
ClearPoint Neuro
CLPT
|
16.5 M | $ 11.11 | -0.94 % | $ 315 M | ||
|
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | ||
|
Sintx Technologies
SINT
|
6.2 M | $ 2.38 | 1.26 % | $ 6.6 M | ||
|
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | ||
|
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | ||
|
Stryker Corporation
SYK
|
8.65 B | $ 324.55 | -1.36 % | $ 124 B | ||
|
Tactile Systems Technology
TCMD
|
88.7 M | $ 23.66 | -2.39 % | $ 541 M | ||
|
TELA Bio
TELA
|
15.7 M | $ 0.77 | -4.03 % | $ 36.1 M | ||
|
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B | ||
|
TransMedics Group
TMDX
|
185 M | $ 104.23 | -3.6 % | $ 3.54 B | ||
|
Tandem Diabetes Care
TNDM
|
445 M | $ 19.31 | -2.57 % | $ 1.31 B | ||
|
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
101 M | $ 1.25 | -2.23 % | $ 50.9 M | ||
|
Butterfly Network
BFLY
|
39.8 M | $ 5.46 | -0.36 % | $ 1.16 B | ||
|
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | ||
|
OrthoPediatrics Corp.
KIDS
|
120 M | $ 15.73 | -0.57 % | $ 369 M | ||
|
Varex Imaging Corporation
VREX
|
133 M | $ 12.58 | -1.0 % | $ 521 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 10.73 | -1.06 % | $ 384 M | ||
|
Vivos Therapeutics
VVOS
|
27.7 M | $ 0.88 | 2.54 % | $ 9.04 M | ||
|
LivaNova PLC
LIVN
|
549 M | $ 63.09 | -0.5 % | $ 3.44 B | ||
|
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.05 | -2.78 % | $ 17.8 M | ||
|
CONMED Corporation
CNMD
|
132 M | $ 37.54 | -0.87 % | $ 1.17 B | ||
|
Inspire Medical Systems
INSP
|
625 M | $ 55.68 | 1.11 % | $ 1.64 B | ||
|
Integer Holdings Corporation
ITGR
|
212 M | $ 84.75 | -0.7 % | $ 2.94 B |